[Causes of changes in bronchiolar caliber: bases and agents for therapy of bronchiolar obstruction].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000209:etiology; D001982:Bronchial Diseases / Q000188:drug therapy / Q000209:etiology*; D001986:Bronchial Spasm / Q000188:drug therapy / Q000209:etiology; D001991:Bronchitis / Q000150:complications / Q000188:drug therapy; D002614:Chelating Agents / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D013501:Surface-Active Agents / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use*
D000318:Adrenergic beta-Agonists; D002614:Chelating Agents; D005100:Expectorants; D006634:Histamine H1 Antagonists; D013501:Surface-Active Agents; D013566:Sympathomimetics
Cause di alterazione del calibro bronchiolare: basi e mezzi per una terapia della bronchiolo-ostruzione